A microfluidic system for monitoring glucagon secretion from human pancreatic islets of Langerhans.


Journal

Analytical methods : advancing methods and applications
ISSN: 1759-9679
Titre abrégé: Anal Methods
Pays: England
ID NLM: 101519733

Informations de publication

Date de publication:
28 08 2021
Historique:
pubmed: 27 7 2021
medline: 18 9 2021
entrez: 26 7 2021
Statut: ppublish

Résumé

Glucagon is a 29-amino acid peptide released from α-cells within pancreatic islets of Langerhans to help raise blood glucose levels. While a plethora of methodologies have been developed for quantitative measurement of insulin released from islets, such methods are not well developed for glucagon despite its importance in blood sugar regulation. In this work, a simple yet robust microfluidic device was developed for holding human pancreatic islets and perfuse them with glucose. The perfusate was collected into 2 min fractions and glucagon quantified using a homogeneous time-resolved Förster resonance energy transfer (TR-FRET) sandwich immunoassay. Simulation of fluid flow within the microfluidic device indicated the device produced low amounts of shear stress on islets, and characterization of the flow with standard glucagon solutions revealed response times within 2 fractions (<4 min). Results with human islets from multiple donors demonstrated either a "burst" of glucagon or a "sustained" glucagon release across the entire period of stimulation. The simplicity, yet robustness, of the device and method is expected to appeal to a number of researchers examining pancreatic islet physiology.

Identifiants

pubmed: 34308945
doi: 10.1039/d1ay00703c
pmc: PMC8375491
mid: NIHMS1735709
doi:

Substances chimiques

Insulin 0
Glucagon 9007-92-5

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3614-3619

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK080714
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK116283
Pays : United States

Références

Anal Chem. 2019 Apr 16;91(8):5184-5190
pubmed: 30884946
Lab Chip. 2019 Sep 10;19(18):2993-3010
pubmed: 31464325
Anal Bioanal Chem. 2012 Mar;402(9):2797-803
pubmed: 22286080
Lab Chip. 2016 Feb 7;16(3):409-31
pubmed: 26732665
Lab Chip. 2018 Sep 26;18(19):2926-2935
pubmed: 30112543
Anal Chem. 2013 Aug 20;85(16):7919-25
pubmed: 23848226
Mol Metab. 2019 Dec;30:230-239
pubmed: 31767174
Annu Rev Anal Chem (Palo Alto Calif). 2016 Jun 12;9(1):249-69
pubmed: 27306310
JCI Insight. 2020 May 21;5(10):
pubmed: 32352931
Lab Invest. 2010 Nov;90(11):1661-75
pubmed: 20697378
Anal Chem. 2003 Sep 15;75(18):4711-7
pubmed: 14674445
J Mol Biol. 2020 Mar 6;432(5):1367-1394
pubmed: 31954131
Anal Chem. 2011 Sep 15;83(18):7166-72
pubmed: 21806019
Diabetes. 2010 Oct;59(10):2360-5
pubmed: 20622164
J Chromatogr A. 2021 Jan 25;1637:461805
pubmed: 33360778
J Biol Chem. 2013 Feb 8;288(6):3938-51
pubmed: 23266825
PLoS One. 2011;6(9):e24904
pubmed: 21961048
Lab Chip. 2009 Jan 7;9(1):97-106
pubmed: 19209341
Lab Chip. 2018 Sep 11;18(18):2873-2882
pubmed: 30109329
Analyst. 2016 Mar 21;141(6):1939-46
pubmed: 26881276
Nat Commun. 2021 Apr 23;12(1):2397
pubmed: 33893274
Anal Chem. 2016 Nov 1;88(21):10368-10373
pubmed: 27712062
Lab Chip. 2015 Feb 7;15(3):823-32
pubmed: 25474044
Anal Chem. 2016 Jan 5;88(1):381-94
pubmed: 26620153
Anal Chem. 2009 Nov 1;81(21):9086-95
pubmed: 19874061
Anal Methods. 2019 Dec 7;11(45):5768-5775
pubmed: 31983930
Front Physiol. 2012 Sep 04;3:349
pubmed: 22969729
Curr Diab Rep. 2014 Dec;14(12):555
pubmed: 25344790
Anal Chem. 2007 Feb 1;79(3):947-54
pubmed: 17263320
Lab Chip. 2017 Feb 28;17(5):772-781
pubmed: 28157238

Auteurs

Wesley J Eaton (WJ)

Department of Chemistry and Biochemistry, Florida State University, 95 Chieftain Way, Tallahassee, FL 32306, USA. mroper@fsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH